Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash & Current Investments (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Cash & Current Investments for 16 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 5.72% to $3.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was $3.3 million, a 5.72% decrease, with the full-year FY2025 number at $3.3 million, down 5.72% from a year prior.
  • Cash & Current Investments was $3.3 million for Q4 2025 at Cryo Cell International, up from $265207.0 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $11.4 million in Q1 2021 to a low of $265207.0 in Q3 2025.
  • A 5-year average of $3.6 million and a median of $2.7 million in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: surged 256.66% in 2024, then tumbled 87.53% in 2025.
  • Cryo Cell International's Cash & Current Investments stood at $8.3 million in 2021, then tumbled by 79.35% to $1.7 million in 2022, then crashed by 43.06% to $980250.0 in 2023, then soared by 256.66% to $3.5 million in 2024, then fell by 5.72% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Cash & Current Investments are $3.3 million (Q4 2025), $265207.0 (Q3 2025), and $4.4 million (Q2 2025).